Related Experiment Video
Updated: May 15, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Combining clinically benign IDUA variants in cis reduces enzymatic activity of the resulting enzyme within the
Seok-Ho Yu1, Laura Pollard1, Heather Flanagan-Steet1
1Greenwood Genetic Center, Greenwood, SC 29646, United States of America.
Abstract:
Interpretation of genotypes with multiple variants can be challenging as independent effects of each variant must be determined to predict the overall outcome for biallelic conditions. This is especially difficult when two or more variants exist in cis on a single allele. We used an established functional platform to characterize the impact of different clinically benign IDUA variants alone, or in combination, demonstrating that the relative specific activity of in cis variant combinations is comparable to individual variants associated with attenuated or even severe MPSI. These results reinforce the concept that combinations of otherwise clinically benign variants can produce pathogenic consequences.
More Related Videos
00:06In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024